Literature DB >> 11040149

Community acquired pneumonia--a prospective UK study.

P Drummond1, J Clark, J Wheeler, A Galloway, R Freeman, A Cant.   

Abstract

BACKGROUND: There are few data on paediatric community acquired pneumonia (PCAP) in the UK. AIMS: To investigate the aetiology and most useful diagnostic tests for PCAP in the north east of England.
METHODS: A prospective study of hospital admissions with a diagnosis of PCAP.
RESULTS: A pathogen was isolated from 60% (81/136) of cases, and considered a definite or probable cause of their pneumonia in 51% (70/136). Fifty (37%) had a virus implicated (65% respiratory syncytial virus) and 19 (14%) a bacterium (7% group A streptococcus, 4% Streptococcus pneumoniae), with one mixed infection. Of a subgroup (51 patients) in whom serum antipneumolysin antibody testing was performed, 6% had evidence of pneumococcal infection, and all were under 2 years old. The best diagnostic yield was from paired serology (34%, 31/87), followed by viral immunofluorescence (33%, 32/98).
CONCLUSION: Viral infection accounted for 71% of the cases diagnosed. Group A streptococcus was the most common bacterial infective agent, with a low incidence of both Mycoplasma pneumoniae and S pneumoniae. Pneumococcal pneumonia was the most common bacterial cause of pneumonia in children under 2 years but not in older children. Inflammatory markers and chest x ray features did not differentiate viral from bacterial pneumonia; serology and viral immunofluorescence were the most useful diagnostic tests.

Entities:  

Mesh:

Year:  2000        PMID: 11040149      PMCID: PMC1718544          DOI: 10.1136/adc.83.5.408

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

1.  Problems in determining the etiology of community-acquired childhood pneumonia.

Authors:  D Isaacs
Journal:  Pediatr Infect Dis J       Date:  1989-03       Impact factor: 2.129

2.  Hospital admissions in children due to pneumococcal pneumonia in England.

Authors:  T Djuretic; M J Ryan; E Miller; C K Fairley; D Goldblatt
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

3.  Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR.

Authors:  R Dagan; O Shriker; I Hazan; E Leibovitz; D Greenberg; F Schlaeffer; R Levy
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

4.  Etiology and treatment of community-acquired pneumonia in ambulatory children.

Authors:  L Wubbel; L Muniz; A Ahmed; M Trujillo; C Carubelli; C McCoig; T Abramo; M Leinonen; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1999-02       Impact factor: 2.129

5.  Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.

Authors:  B A Claesson; B Trollfors; I Brolin; M Granström; J Henrichsen; U Jodal; P Juto; I Kallings; K Kanclerski; T Lagergård
Journal:  Pediatr Infect Dis J       Date:  1989-12       Impact factor: 2.129

6.  Etiology of childhood pneumonia: serologic results of a prospective, population-based study.

Authors:  T Heiskanen-Kosma; M Korppi; C Jokinen; S Kurki; L Heiskanen; H Juvonen; S Kallinen; M Stén; A Tarkiainen; P R Rönnberg; M Kleemola; P H Mäkelä; M Leinonen
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

7.  Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children.

Authors:  H Nohynek; E Valkeila; M Leinonen; J Eskola
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129

8.  C-reactive protein in viral and bacterial respiratory infection in children.

Authors:  M Korppi; L Kröger
Journal:  Scand J Infect Dis       Date:  1993

9.  Community-acquired infections among children in an urban environment: a 2-year prospective study in Liverpool, U.K.

Authors:  P Shears; A Wright
Journal:  J Infect       Date:  1995-03       Impact factor: 6.072

10.  Aetiology of community-acquired pneumonia in children treated in hospital.

Authors:  M Korppi; T Heiskanen-Kosma; E Jalonen; P Saikku; M Leinonen; P Halonen; P H Mäkela
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

View more
  24 in total

1.  Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland.

Authors:  M Patrzałek; P Albrecht; M Sobczynski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-01       Impact factor: 3.267

2.  Streptococcus pneumoniae as a frequent cause of severe community-acquired pneumonia among children in Beijing.

Authors:  H Hu; L He; S Yu; K Yao; A Dmitriev; J Deng; C Zhao; X Shen; Y Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 3.267

3.  Indirect population impact of universal PCV7 vaccination of children in a 2 + 1 schedule on the incidence of pneumonia morbidity in Kielce, Poland.

Authors:  M Patrzalek; P Gorynski; P Albrecht
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-16       Impact factor: 3.267

4.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

5.  Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.

Authors:  Maria C Magnus; Didrik F Vestrheim; Wenche Nystad; Siri Eldevik Håberg; Hein Stigum; Stephanie J London; Marianne A R Bergsaker; Dominique A Caugant; Ingeborg S Aaberge; Per Nafstad
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

6.  Quantitative detection of Streptococcus pneumoniae in nasopharyngeal secretions by real-time PCR.

Authors:  O Greiner; P J Day; P P Bosshard; F Imeri; M Altwegg; D Nadal
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients.

Authors:  H H Huang; Y Y Zhang; Q Y Xiu; X Zhou; S G Huang; Q Lu; D M Wang; F Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

8.  Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.

Authors:  Maria Atkinson; Monica Lakhanpaul; Alan Smyth; Harish Vyas; Vivienne Weston; Jabulani Sithole; Victoria Owen; Katharine Halliday; Helen Sammons; Jo Crane; Narayan Guntupalli; Lynda Walton; Titus Ninan; Anu Morjaria; Terence Stephenson
Journal:  Thorax       Date:  2007-06-13       Impact factor: 9.139

Review 9.  Management of community-acquired pneumonia in children.

Authors:  Krishne Chetty; Anne H Thomson
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 10.  Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.

Authors:  Kay Wang; Peter Gill; Rafael Perera; Anne Thomson; David Mant; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.